Closing The Evidence Gap For Orphan Drugs- Do German Regulatory Requirements Give Incentives For High Level Evidence Generation?
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.675
https://www.valueinhealthjournal.com/article/S1098-3015(17)31009-4/fulltext
Title :
Closing The Evidence Gap For Orphan Drugs- Do German Regulatory Requirements Give Incentives For High Level Evidence Generation?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31009-4&doi=10.1016/j.jval.2017.08.675
First page :
A518
Section Title :
Health Care Treatment Studies
Open access? :
No
Section Order :
645